Does levodopa accelerate the pathologic process in Parkinson disease brain? von PARKKINEN, L, O'SULLIVAN, S. S, KUOPPAMAKI, M, COLLINS, C, KALLIS, C, HOLTON, J. L, WILLIAMS, D. R, REVESZ, T, LEES, A. J

Volltext

Pooled analysis of phase III with entacapone in Parkinson's disease von Kuoppamäki, M., Vahteristo, M., Ellmén, J., Kieburtz, K.

Volltext

Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial von Cudkowicz, Merit, Maragakis, Nicholas, Petri, Susanne, van den Berg, Leonard, Aho, Valtteri V, Sarapohja, Toni, Kuoppamäki, Mikko, Garratt, Chris, Al-Chalabi, Ammar, Kiernan, Matthew, Mathers, Susan, Henderson, Robert, Needham, Merrilee, Schultz, David, Löscher, Wolfgang, Mitrovic, Nenad, Rath, Jakob, Damme, Philip Van, De Bleecker, Jan L., Delstanche, Stéphanie, Johnston, Wendy, Zinman, Lorne, O'Connell, Colleen, Matte, Genevieve, Dionne, Annie, Korngut, Lawrence, Turnbull, John, Laaksovirta, Hannu, Jokela, Manu, Tapiola, Tero, Soriani, Marie-Hélène, Couratier, Philippe, Camu, William, Corcia, Philippe, Ludolph, Albert, Großkreutz, Julian, Meyer, Thomas, Boentert, Matthias, Prudlo, Johannes, Untucht, Robert, Hardiman, Orla, Siciliano, Gabriele, Chio', Adriano, Mazzini, Letizia, Inghilleri, Maurizio, Caponnetto, Claudia, Mora, Gabriele, Mora Pardina, Jesús S, Farrero Munoz, Eva, Vázquez Costa, Juan F, Aguera Morales, Eduardo, Varona, Luis, Andersen, Peter, Ingre, Caroline, Johansson, Rune, Radunovic, Aleksandar, Young, Carolyn, Babu, Suma, Shaibani, Aziz, Staff, Nathan, Vu, Tuan, Rivner, Michael, Scelsa, Stephen, Sivakumar, Kumaraswamy, Waheed, Waqar, Heitzman, Daragh, Rana, Sandeep, Pattee, Gary, Bayat, Elham, Kasarskis, Edward, Lange, Dale J, Elliott, Michael, Harris, Brent, Felice, Kevin, Pulley, Michael T, Kwan, Justin, Brown, Martin, Ravits, John, Burford, Matthew, Karam, Chafic, Miller, Timothy, Andrews, Jinsy, Levine, Todd, Locatelli, Eduardo, Wymer, James, Bedlack, Richard, Fee, Dominic, Goyal, Namita, Oskarsson, Bjorn, McCluskey, Leo, Caress, James, Weiss, Michael, Quick, Adam, Bromberg, Mark, Lacomis, David, Goutman, Stephen, Rezania, Kourosh, Guliani, Gaurav, Goslin, Kimberly, Katz, Jonathan S

Volltext

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia von Hietala, Jarmo, Syvälahti, Erkka, Vilkman, Harry, Vuorio, Klaus, Räkköläinen, Viljo, Bergman, Jörgen, Haaparanta, Merja, Solin, Olof, Kuoppamäki, Mikko, Eronen, Esa, Ruotsalainen, Ulla, Salokangas, Raimo K.R.

Volltext

MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome von Zeng, B-Y., Iravani, M. M., Lin, S-T., Irifune, M., Kuoppamäki, M., Al-Barghouthy, G., Smith, L., Jackson, M. J., Rose, S., Medhurst, A. D., Jenner, P.

Volltext

Early versus delayed initiation of entacapone in levodopa-treated patients with Parkinson's disease: a long-term, retrospective analysis von Nissinen, H., Kuoppamäki, M., Leinonen, M., Schapira, A. H.

Volltext

Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naïve primates von Smith, Lance A., Jackson, Michael J., Al-Barghouthy, Ghassan, Rose, Sarah, Kuoppamaki, Mikko, Olanow, Warren, Jenner, Peter

Volltext

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients von Hietala, J., Syvälahti, E., Kuoppamäki, M., Hietala, J., Syvälahti, E., Haaparanta, M., Kuoppamäki, M., Ruotsalainen, U., Vuorio, K., Räkköläinen, V., Bergman, J., Solin, O., Kirvelä, O., Salokangas, R.K.R.

Volltext

The metabolic syndrome defined by modified International Diabetes Federation criteria and mortality: A 9-year follow-up of the aged in Finland von Salminen, M, Kuoppamäki, M, Vahlberg, T, Räihä, I, Irjala, K, Kivelä, S.L

Volltext

Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography von Tiihonen, J, Vilkman, H, Räsänen, P, Ryynänen, O-P, Hakko, H, Bergman, J, Hämäläinen, T, Laakso, A, Haaparanta-Solin, M, Solin, O, Kuoppamäki, M, Syvälahti, E, Hietala, J

Volltext

3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates von Iravani, Mahmoud M, Jackson, Michael J, Kuoppamaki, Mikko, Smith, Lance A, Jenner, Peter

Volltext

L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates von Kuoppamäki, M., Al-Barghouthy, G., Jackson, M. J., Smith, L. A., Quinn, N., Jenner, P.

Volltext

Parkinsonism following bilateral lesions of the globus pallidus: performance on a variety of motor tasks shows similarities with Parkinson’s disease von Kuoppamäki, M, Rothwell, J C, Brown, R G, Quinn, N, Bhatia, K P, Jahanshahi, M

Volltext

Entacapone did not Increase Prostate Cancer Risk or Mortality in Patients with Parkinson's Disease von Korhonen, P, Kuoppamäki, M, Prami, T, Hoti, F, Christopher, S, Ellmén, J, Aho, V, Vahteristo, M, Pukkala, E, Haukka, J

Volltext

Risk of dyskinesia in Parkinson's disease patients who already have developed wearing-off: A secondary analysis of STRIDE-PD study von Olanow, C.W, Kieburtz, K, Rascol, O, Poewe, W, Schapira, A.H.H, Kuoppamäki, M, Nissinen, H, Leinonen, M, Stocchi, F

Volltext

Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor von PÄLVIMÄKI, E.-P, ROTH, B. L, MAJASUO, H, LAAKSO, A, KUOPPAMÄKI, M, SYVÄLAHTI, E, HIETALA, J

Volltext

Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates von Smith, Lance A, Jackson, Michael J, Johnston, Louisa, Kuoppamaki, Mikko, Rose, Sarah, Al-Barghouthy, Ghassan, Del Signore, Susanna, Jenner, Peter

Volltext

Progressive delayed-onset dystonia after cerebral anoxic insult in adults von Kuoppamäki, Mikko, Bhatia, Kailash P., Quinn, Niall

Volltext

Fast micrographia and pallidal pathology von Quinn, Niall, Kuoppamäki, Mikko

Volltext

Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study von Kivikko, Matti, MD, PhD, Kuoppamäki, Mikko, MD, PhD, Soinne, Lauri, MD, PhD, Sundberg, Stig, PhD, Pohjanjousi, Pasi, MSc, Ellmen, Juha, PhD, Roine, Risto O., MD, PhD

Volltext